BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 38505602)

  • 1. RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential.
    Qu J; Yan H; Hou Y; Cao W; Liu Y; Zhang E; He J; Cai Z
    J Hematol Oncol; 2022 Jan; 15(1):8. PubMed ID: 35063010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FSH induces EMT in ovarian cancer via ALKBH5-regulated Snail m6A demethylation.
    Xu X; Zhuang X; Yu H; Li P; Li X; Lin H; Teoh JP; Chen Y; Yang Y; Cheng Y; Chen W; Fu X
    Theranostics; 2024; 14(5):2151-2166. PubMed ID: 38505602
    [No Abstract]   [Full Text] [Related]  

  • 3. Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K/Akt-Snail signaling pathway.
    Yang Y; Zhang J; Zhu Y; Zhang Z; Sun H; Feng Y
    Int J Gynecol Cancer; 2014 Nov; 24(9):1564-74. PubMed ID: 25340291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-κB pathway.
    Jiang Y; Wan Y; Gong M; Zhou S; Qiu J; Cheng W
    J Cell Mol Med; 2020 Jun; 24(11):6137-6148. PubMed ID: 32329191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALKBH5 activates FAK signaling through m6A demethylation in
    Sun R; Yuan L; Jiang Y; Wan Y; Ma X; Yang J; Sun G; Zhou S; Wang H; Qiu J; Zhang L; Cheng W
    Theranostics; 2023; 13(2):833-848. PubMed ID: 36632222
    [No Abstract]   [Full Text] [Related]  

  • 6. ALKBH5-mediated m
    Hao L; Yin J; Yang H; Li C; Zhu L; Liu L; Zhong J
    Aging (Albany NY); 2021 Jan; 13(3):4045-4062. PubMed ID: 33428593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer.
    Nie S; Zhang L; Liu J; Wan Y; Jiang Y; Yang J; Sun R; Ma X; Sun G; Meng H; Xu M; Cheng W
    J Exp Clin Cancer Res; 2021 Sep; 40(1):284. PubMed ID: 34496932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity and treatment landscape of ovarian carcinoma.
    Veneziani AC; Gonzalez-Ochoa E; Alqaisi H; Madariaga A; Bhat G; Rouzbahman M; Sneha S; Oza AM
    Nat Rev Clin Oncol; 2023 Dec; 20(12):820-842. PubMed ID: 37783747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m6A-modified circNFIX promotes ovarian cancer progression and immune escape via activating IL-6R/JAK1/STAT3 signaling by sponging miR-647.
    Wang R; Ye H; Yang B; Ao M; Yu X; Wu Y; Xi M; Hou M
    Int Immunopharmacol; 2023 Nov; 124(Pt A):110879. PubMed ID: 37713785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synergistic effect of EMT regulators and m6A modification on prognosis-related immunological signatures for ovarian cancer.
    Zhang Y; Wang X; Duan X; Du T; Chen X
    Sci Rep; 2023 Sep; 13(1):14872. PubMed ID: 37684273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF2BP2 promotes ovarian cancer growth and metastasis by upregulating CKAP2L protein expression in an m
    Shi Y; Xiong X; Sun Y; Geng Z; Chen X; Cui X; Lv J; Ge L; Jia X; Xu J
    FASEB J; 2023 Oct; 37(10):e23183. PubMed ID: 37665628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological targeting of netrin-1 inhibits EMT in cancer.
    Lengrand J; Pastushenko I; Vanuytven S; Song Y; Venet D; Sarate RM; Bellina M; Moers V; Boinet A; Sifrim A; Rama N; Ducarouge B; Van Herck J; Dubois C; Scozzaro S; Lemaire S; Gieskes S; Bonni S; Collin A; Braissand N; Allard J; Zindy E; Decaestecker C; Sotiriou C; Salmon I; Mehlen P; Voet T; Bernet A; Blanpain C
    Nature; 2023 Aug; 620(7973):402-408. PubMed ID: 37532929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic modification of m
    Wang Y; Wang Y; Patel H; Chen J; Wang J; Chen ZS; Wang H
    Mol Cancer; 2023 Jun; 22(1):102. PubMed ID: 37391814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METTL3 achieves lipopolysaccharide-induced myocardial injury via m
    Gong C; Wu J; Li H; Luo C; Ji G; Guan X; Liu J; Wang M
    Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119503. PubMed ID: 37245538
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.